Cargando…
Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options
Despite intensive studies, the clinical opportunities for patients with fibrosing liver diseases have not improved. This will be changed by increasing knowledge of new pathogenetic mechanisms, which complement the "canonical principle" of fibrogenesis. The latter is based on the activation...
Autores principales: | Gressner, Olav A, Weiskirchen, Ralf, Gressner, Axel M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994681/ https://www.ncbi.nlm.nih.gov/pubmed/17663771 http://dx.doi.org/10.1186/1476-5926-6-7 |
Ejemplares similares
-
Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality
por: Gressner, OA, et al.
Publicado: (2007) -
Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets
por: Gressner, A M, et al.
Publicado: (2006) -
Activation of TGF-β within cultured hepatocytes and in liver injury leads to intracrine signaling with expression of connective tissue growth factor
por: Gressner, Olav A, et al.
Publicado: (2008) -
Immortal hepatic stellate cell lines: useful tools to study hepatic stellate cell biology and function?
por: Herrmann, Jens, et al.
Publicado: (2007) -
Mast Cells in Liver Fibrogenesis
por: Weiskirchen, Ralf, et al.
Publicado: (2019)